Predicted Coverage and Immuno-Safety of a Recombinant C-Repeat Region Based Streptococcus pyogenes Vaccine Candidate.

about

Predicted Coverage and Immuno-Safety of a Recombinant C-Repeat Region Based Streptococcus pyogenes Vaccine Candidate.

Item

http://www.wikidata.org/entity/Q36054412

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Predicted Coverage and Immuno- ...... us pyogenes Vaccine Candidate.

@ast

Predicted Coverage and Immuno- ...... us pyogenes Vaccine Candidate.

@en

type

Item

label

Predicted Coverage and Immuno- ...... us pyogenes Vaccine Candidate.

@ast

Predicted Coverage and Immuno- ...... us pyogenes Vaccine Candidate.

@en

prefLabel

Predicted Coverage and Immuno- ...... us pyogenes Vaccine Candidate.

@ast

Predicted Coverage and Immuno- ...... us pyogenes Vaccine Candidate.

@en

P1476

Predicted Coverage and Immuno- ...... us pyogenes Vaccine Candidate.

@en

P2093

Anne Fane

http://www.w3.org/2001/XMLSchema#string

Celia McNeilly

http://www.w3.org/2001/XMLSchema#string

Jemma Nichols

http://www.w3.org/2001/XMLSchema#string

Louise M Hafner

http://www.w3.org/2001/XMLSchema#string

Natkuman Ketheesan

http://www.w3.org/2001/XMLSchema#string

Therese Vu

http://www.w3.org/2001/XMLSchema#string

P2860

Protein structure prediction servers at University College London

Animal models to investigate the pathogenesis of rheumatic heart disease

Strategies in the development of vaccines to prevent infections with group A streptococcus

Structure-Informed Design of an Enzymatically Inactive Vaccine Component for Group A Streptococcus

SDAR: a practical tool for graphical analysis of two-dimensional data

Streptococcal M protein: molecular design and biological behavior.

Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study.

Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB.

Spread of a highly mucoid Streptococcus pyogenes emm3/ST15 clone.

The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design.

P304

e0156639

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0156639

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27310707

http://www.w3.org/2001/XMLSchema#string

P932

4911098

http://www.w3.org/2001/XMLSchema#string